Adrien Wing began his professional career practising in the audit and corporate advisory divisions within a boutique chartered accounting firm. With a career spanning over 25 years, Mr. Wing has been a prominent figure in the corporate landscape, focusing primarily on ASX small-cap companies. His expertise shines through in his leadership in IPO transactions and his pivotal role in orchestrating post-listing reverse takeovers and acquisitions across diverse industry sectors and global jurisdictions.

Mr Wing has a strong pedigree in the life sciences industry being the founder of Rhythm Biosciences Ltd (ASX:RHY) and bringing that entity to the ASX in 2017. His profound knowledge and invaluable experience make him a compelling candidate for appointment as a non-executive director.

Mr Wing currently serves as an officer/director on the following company boards: (i) Cleo Diagnostics Ltd (ASX: COV) – Non-Executive Chair; (ii) Red Sky Energy Ltd (ASX: ROG) – Director and Joint Company Secretary; (iii) New Age Exploration Ltd (ASX: NAE) – Director and Joint Company Secretary; and (iv) Osmond Resources Ltd (ASX: OSM) – Company Secretary.